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Objectives: Lower urinary tract symptoms (LUTS) are highly prevalent in aging men. In this study we
examined the relationship between age, total prostate volume (TPV), and videourodynamic study
ﬁndings.
Methods: We retrospectively analyzed a total of 971 men  40 years of age referred to us for investi-
gation of LUTS. We analyzed the distribution of the different videourodynamic study diagnoses in male
LUTS by correlating their age and prostate size.
Results: The most common diagnosis in the bladder outlet obstruction (BOO) group differed signiﬁcantly
by age and poor relaxation of the external sphincter (PRES) in those aged < 50 years; bladder neck
dysfunction in those aged 50e69 years, and benign prostatic obstruction in those  60 years. Detrusor
overactivity was the most common diagnosis in all ages in the bladder dysfunction group, and the cases
of hyperactivity with impaired contractility (DHIC) increased with age. In patients < 50 years of age, PRES
was the most common diagnosis in the BOO group in both those with small prostates (total prostate
volume  40 mL) and large prostates (total prostate volume > 40 mL). In patients aged 50e69 years, the
most common diagnosis in those with BOO and a small prostate was bladder neck dysfunction, and that
in those with BOO and a large prostate was benign prostatic obstruction. Similar results were observed in
patients aged  70 years. In all age groups, the majority of patients with detrusor overactivity, hyper-
sensitive bladder, detrusor underactivity, and DHIC had a small prostate.
Conclusion: In male LUTS, the diagnoses in the BOO group differed by age and prostate volume. In young
patients with BOO, the leading diagnosis was PRES, and the contribution of prostate volume to BOO
increased with age. As age increased, the bladder function became more complex with an increased
percentage of patients with DHIC. Both bladder outlet and bladder functions were affected by age.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lower urinary tract symptoms (LUTS) are among the most
common and socially disruptive conditions encountered in uro-
logical practiceworldwide. The overall prevalence of LUTS inmen is
18.7%. The prevalence is lowest among men 30e39 years old
(10.5%) and increases with age until a maximum in the 7th decade
(26.5%).1 LUTS is an umbrella term that encompasses storage
symptoms (frequency, urgency, nocturia, urge incontinence),
voiding symptoms (dysuria, hesitancy, intermittency, slow stream,ddhist Tzu Chi General Hos-
an.
ociation. Published by Elsevier Tastraining, terminal dribble), and post micturition symptoms
(sensation of incomplete emptying, post micturition dribble).2 An
estimated 10% of Taiwanese men older than 40 years have at least
one bothersome LUTS.3
In the past, the prostate was blamed for just about every uri-
nation issue in elderly men. However, recent statistics have shown
that only 25e50% of men with benign prostatic hyperplasia (BPH)
have LUTS, and only 50% of men who present with LUTS have
urodynamically-proven bladder outlet obstruction (BOO) due to
BPH or another urethral pathology.4
It is now widely acknowledged that although prostate
enlargement can lead to the onset of male LUTS, other vesicogenic
factors including detrusor overactivity (DO), nocturnal polyuria,
detrusor underactivity (DU), neurogenic bladder dysfunction,iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
C.-L. Lee, H.-C. Kuo / Urological Science 27 (2016) 21e2522urinary tract infection, prostatitis, urethral stricture, bladder tumor,
and urolithiasis are also etiologies.5 Aging, obesity, glucose intol-
erance, and hypertension may also contribute to LUTS.6,7 Given the
wide variety of pathogeneses, identifying the underlying causes of
LUTS based on symptoms alone is often difﬁcult and incorrect.8
Videourodynamic study (VUDS), however, is described as the gold
standard investigation for patients with LUTS.9 It is a dynamic
integration of urine ﬂow, pressure changes, and imaging studies
during the bladder ﬁlling and emptying phases, and provides
objective information to form an accurate diagnosis and formulate
a tailored treatment plan. In this retrospective study, we discuss the
different pathophysiologies underlying male LUTS and analyze the
relationship between age, prostate size, and VUDS ﬁndings.2. Patients and methods
We retrospectively reviewed men aged  40 years who had
undergone a VUDS for investigation of LUTS at our institution be-
tween August 1997 and November 2012. This study was approved
by the Institutional Review Board and the Ethics Committee of
Buddhist Tzu Chi General Hospital, Hualien, Taiwan (IRB 104-15-B).
The eligible 971 cases for analysis had no active urinary tract
infection, interstitial cystitis, occult or overt neuropathy (including
cerebrovascular accident, diabetes mellitus, multiple sclerosis,
Parkinson's disease, spinal cord injury), previous transurethral
surgery, or prostatectomy. The International Prostatic Symptom
Score and Quality of Life index questionnaire was used to assess the
severity of LUTS.10 A signiﬁcant bothersome symptom was deﬁned
by a score greater than 3. All enrolled patients were required to
have at least one storage symptom and one voiding symptom in
conjunctionwith an International Prostatic Symptom Score 8 and
a QoL index  3. Total prostate volume (TPV) was measured using
transrectal ultrasound. Based on their clinical diagnoses, patients
considered to have benign prostatic obstruction (BPO) were treated
empirically with alpha-blockers, and those considered to have an
overactive bladder were treated with antimuscarinic agents.
A VUDS was conducted in those with LUTS that persisted for at
least 1 month after initial treatment. The VUDS was set up in
accordance with the recommendations of the International Conti-
nence Society using C-arm ﬂuoroscopy and performed solely by an
experienced urologist.11 The maximum ﬂow rate (Qmax), voiding
detrusor pressure at Qmax (Pdet.Qmax), postvoiding residual vol-
ume, sphincter electromyography (EMG) activity, and voiding
cystourethrography were documented for the diagnosis of lower
urinary tract dysfunction. VUDS was repeated at least twice to
obtain a reproducible pressure ﬂow tracing. BPO, bladder neck
dysfunction (BND), poor relaxation of the urethral sphincter (PRES),
hypersensitive ladder (HSB), DO, DU, and detrusor hyperactivity
with impaired contractility (DHIC) were diagnosed according to the
VUDS ﬁndings.12Table 1
Numerical display of lower urinary tract dysfunction underlying lower urinary tract sym
Age (n) Bladder outlet dysfunction
BND (243) BPO (317) PRES (116) Total DO (1
40e49 6 (26.1) 4 (17.4) 13 (56.5) 23 3 (
50e59 39 (43.8) 32 (36.0) 18 (20.2) 89 15 (
60e69 78 (46.2) 57 (33.7) 34 (20.1) 169 30 (
70e79 73 (29.9) 136 (55.7) 35 (14.3) 244 70 (
80 47 (31.1) 88 (58.3) 16 (10.6) 151 59 (
Total 243 (25) 317 (32.6) 116 (11.9) 676 (69.6) 177 (
Data are presented as n (%).
BND¼ bladder neck dysfunction; BPO ¼ benign prostatic obstruction; DHIC ¼ detrusor hy
underactivity; HSB ¼ hypersensitive bladder; PRES: poor relaxation of external sphincteBPO was characterized by a Pdet.Qmax  50 cm H2O or an
Abrams-Grifﬁths number (PdetQmax-2Qmax)  40. In equivocal
cases, the features of the bladder neck, prostatic urethra, and
external sphincter on voiding cystourethrography aided in making
a diagnosis of BOO. DO was deﬁned as any involuntary phasic
detrusor contraction occurring during the ﬁlling phase, and HSB
was deﬁned as an early ﬁrst sensation of bladder ﬁlling that
occurred at low bladder volume (< 250 mL) and persisted. If
sphincter EMG showed relaxed activity with an open membranous
urethra during voiding, a low ﬂow rate was considered to be due to
DU. However, if the sphincter EMG showed nonrelaxed activity in
associationwith a narrowmembranous urethra during voiding, the
low-ﬂow rate was regarded as due to low detrusor contractility
induced by PRES.
The results of the VUDS were further stratiﬁed into ﬁve age
groups (40e49 years, 50e59 years, 60e69 years, 70e79 years, and
 80 years) and four prostate size groups ( 30 mL, 31e40 mL,
41e60 mL, and  60 mL). The values of various clinical and uro-
dynamic parameters among patients with and without BPO, and
with and without DO, were expressed as mean ± standard devia-
tion and compared with the t test. All statistical analyses were
carried out with SPSS version 17 (SPSS Inc., Chicago, IL, USA).3. Results
The mean age of these 971 patients was 72 ± 11 years (range,
40e98 years). There were 29 men with LUTS who were younger
than 50 years, 117 patients in the 50e59 years age group, 215 pa-
tients in the 60e69 years age group, 351 men in the 70e79 years
age group, and 259 patients older than 80 years. Age-stratiﬁed
distribution of the VUDS ﬁndings is shown in Table 1.
The underlying pathophysiology in male LUTS could be divided
into BOO (69.6% of patients) and bladder dysfunction (30.4%). The
causes of BOO included BND in 243 patients (25.0%), BPO in 317
patients (32.6%), and PRES in 116 patients (11.9%). The diagnosis in
those with bladder dysfunctionwas DO in 177 patients (18.2%), HSB
in 25 patient (2.6%), DU in 38 patient (3.9%), and DHIC in 55 patient
(5.7%; Figure1). BOO was by far the most common cause of LUTS in
all age groups, especially in the 70e79 years age group. The most
prevalent age-related etiologies in the BOO group were PRES in the
<40e49 years age group and BPO in those aged  50 years. On the
contrary, in patients with bladder dysfunction, DO was the most
common diagnosis in all age groups and along with DHIC, the
incidence rose with age (Table 1).
We examined the VUDS diagnosis based on the TPV alone. Those
with a TPV > 40 mL had a higher incidence of BOO due to BPO (TPV
41e60 mL, 46.3%; TPV  61 mL, 68.3%), whereas in those with a
TPV 40 mL, the incidence of BPO was lower (TPV 31e40 mL,
20.5%; TPV  30 mL, 17.5%; Table 2). BND was the most common
VUDS ﬁnding in those with smaller prostates ( 30 mL andptoms in 971 men by age.
Bladder dysfunction Total
77) HSB (25) DU (38) DHIC (55) Total
50.0) 1 (16.7) 2 (33.3) 0 6 29
53.6) 6 (21.4) 6 (21.4) 1 (3.6) 28 117
65.2) 7 (15.2) 3 (6.5) 6 (13.0) 46 215
65.4) 8 (7.5) 14 (13.1) 15 (14.0) 107 351
54.6) 3 (2.8) 13 (12.0) 33 (30.6) 108 259
18.2) 25 (2.6) 38 (3.9) 55 (5.7) 295 (30.4%) 971
perreﬂexia and inadequate contractility; DO ¼ detrusor overactivity; DU ¼ detrusor
r.
Figure 1. The distribution of etiology of bladder outlet dysfunction and bladder
dysfunction in men with lower urinary tract symptoms. BND ¼ bladder neck
dysfunction; BPO ¼ benign prostatic obstruction; DHIC ¼ detrusor hyperreﬂexia with
impaired contractility; DO ¼ detrusor overactivity; DU ¼ detrusor underactivity;
HSB ¼ hypersensitive bladder; PRES: poor relaxation of external sphincter.
Figure 2. Distribution of bladder outlet dysfunction and bladder dysfunction accord-
ing to age group. BOO ¼ bladder outlet obstruction.
Figure 3. Distribution of bladder outlet obstruction and bladder dysfunction according
to total prostatic volume (mL). BOO ¼ bladder outlet obstruction.
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tients with prostates> 40mL. DOwas highly prevalent in almost all
prostate size groups, especially in those with prostates  60 mL.
Figures 2 and 3 compare the incidence of BOO and bladder
dysfunction in patients in different age groups and prostate volume
groups, respectively. The rate ratio of bladder dysfunction to BOO
increased with increasing age (0.287 in the 40e49 years group vs.
0.802 in the  80 years group; Figure 2). However, the rate ratio of
BOO to bladder dysfunction increased with increasing TPV (1.673 in
the TPV  30 mL group vs. 5.949 in the TPV > 60 mL group;
Figure 3).
By correlating both age and TPV, we found that in patients
younger than 50 years, PRESwas themost common diagnosis in the
BOO group in both the small prostate (TPV  40 mL) group and
large prostate (TPV > 40 mL) group. In the 50e69 years age group,
the most common diagnosis in thosewith BOO and a small prostate
was BND, and that in those with BOO and large prostate was BPO.
Similar results were observed in patients older than 70 years. In all
age groups, the majority of patients with DO, HSB, DU, and DHIC
had a small prostate (Figure 4).
Table 3 compares the clinical characteristics and urodynamic
parameters in patients with BOO and DO, BOO without DO, and DO
without BOO. The presenting symptoms (both storage and empty)
were not signiﬁcantly different among patients with and without
BOO in the presence of DO. Nevertheless, men with BOO or DO had
a signiﬁcantly earlier ﬁrst sensation of ﬁlling, greater voiding
pressure, lower Qmax, and smaller bladder capacity than those
without BOO or DO.Table 2
The distribution of lower urinary tract dysfunction in men with lower urinary tract sym
TPV Bladder outlet dysfunction
BND (243) BPO (317) PRES (116) Total (676) DO (
30 114 (42.5) 75 (28.0) 79 (29.5) 268 98 (6
31e40 59 (51.8) 36 (31.6) 19 (16.7) 114 41 (6
41e60 50 (32.5) 94 (61.0) 10 (6.5) 154 32 (6
61 20 (14.3) 112 (80.0) 8 (5.7) 140 6 (2
Data are presented as n (%).
BND¼ bladder neck dysfunction; BPO ¼ benign prostatic obstruction; DHIC ¼ detrusor hy
underactivity; HSB ¼ hypersensitive bladder; PRES ¼ poor relaxation of external sphinc4. Discussion
LUTS are highly prevalent in aging populations, particularly in
men, and for many years have been managed in a prostate-centric
fashion. However, recent scientiﬁc evidence on BOO and bladder
dysfunction has led to a paradigm shift in managing male LUTS.13
Although many investigators believe that VUDS is invasive, costly,
and does not correlate well with urinary symptoms, it is still
considered the gold standard investigation to identify various
bladder and outlet dysfunctions, including BND, BPO, PRES, DO,
HSB, DU, and DHIC.8,14,15
In male LUTS, the diagnosis in the BOO group was inﬂuenced by
age and prostate volume. Laniado et al16 reported only 48% of men
referred for investigation of LUTS actually had urodynamically-
proven BOO. Interestingly, in this study, nearly 70% of men were
diagnosed with BOO and BPO remained the leading cause of LUTS
in the older population. This is probably explained by the fact that
our study population was slightly older than that in other studiesptoms by total prostate volume.
Bladder dysfunction Total
177) HSB (25) DU (38) DHIC (55) Total (295)
1.3) 17 (10.6) 17 (10.6) 28 (17.5) 160 428
6.1) 5 (8.1) 8 (12.9) 8 (12.9) 62 176
5.3) 2 (4.1) 5 (10.2) 10 (20.4) 49 203
5.0) 1 (4.2) 8 (33.3) 9 (37.5) 24 164
perreﬂexia and inadequate contractility; DO ¼ detrusor overactivity; DU ¼ detrusor
ter; TPV ¼ total prostatic volume.
Figure 4. The effects of age (x-axis) and total prostatic volume (mL) on lower urinary
tract dysfunction in men with lower urinary tract symptoms. BND ¼ bladder neck
dysfunction; BPO ¼ benign prostatic obstruction; DHIC ¼ detrusor hyperreﬂexia with
impaired contractility; DO ¼ detrusor overactivity; DU ¼ detrusor underactivity;
HSB ¼ hypersensitive bladder; PRES ¼ poor relaxation of external sphincter;
TPV ¼ total prostatic volume.
Table 3
Clinical symptoms and urodynamic parameters in patients with bladder outlet








IPSS-T 13.3 ± 8.56 15.3 ± 8.59 16.1 ± 8.72 0.214
IPSS-E 6.70 ± 6.19 8.24 ± 6.21 8.50 ± 6.26 0.251
IPSS-S 6.34 ± 3.88 6.26 ± 3.96 7.66 ± 3.97 0.174
FSF (mL) 108 ± 56.4 155 ± 69.0 117 ± 58.6 0.001
Pdet.Qmax (cmH2O) 64.7 ± 31.3 37.7 ± 25.5 28.7 ± 12.8 0.001
Qmax (mL/s) 7.81 ± 4.80 9.10 ± 5.00 10.3 ± 5.85 0.001
Bladder capacity (mL) 231 ± 115 370 ± 129 244 ± 121 0.001
BOO ¼ bladder outlet obstruction; DO ¼ detrusor overactivity; FSF ¼ ﬁrst sensation
of ﬁlling; IPSS¼ International Prostatic Symptom Score; Pdet.Qmax ¼ detrusor
pressure at maximum ﬂow rate; Qmax ¼ maximum ﬂow rate.
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groups.14 By contrast, we reported PRES and BND were more likely
responsible for LUTS in men younger than 50 years. This result was
similar to what Wang et al17 published in 2003, which stated
nonrelaxing external urethral sphincter and primary neck
obstruction were common causes in young population with small
prostates (< 30 mL). It may be contributed by the dysfunction of
complex sympathetic nervous system.17
The prostate enlarges with age and its volume has been asso-
ciated with LUTS progression.18 Our results indicated that a TPV of
 40mL in patients younger than 60 years had relatively little effect
on their BOO. The volume of the prostate played a more vital role in
BND and BPO in older age groups. On further evaluation, we
demonstrated that cases of DO and DHIC increased in the elderly. In
addition, men with BPO or DO had a signiﬁcantly earlier ﬁrst
sensation of ﬁlling, greater voiding pressure, lower Qmax, and
smaller bladder capacity than men without these conditions. Thismay imply the fact that complexity of bladder function is affected
by age and probably secondary to BOO, especially in those with
chronic symptoms.
We also showed that presenting symptoms (both storage and
empty) were not signiﬁcantly different among patients with and
without BPO in the presence of DO. As concluded in a systematic
review, symptoms alone are not enough to adequately diagnose
BOO.19 The accurate diagnosis of LUTS should be determined by
ﬁndings from a combination of a comprehensive history, physical
examination, and urodynamic study. Hence, unnecessary surgery
can be avoided when suitable medical treatment is available and
the success rate of surgery can be optimized in those who need it.
5. Conclusion
In male LUTS, the diagnosis in the BOO group differed by age and
prostate volume. The leading diagnosis in young patients with BOO
was PRES, and the contribution of TPV to BOO increased with age.
As age increased, bladder function became more complex with an
increased percentage of DHIC. Both bladder outlet and bladder
functions were affected by age.
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